Catheter Precision, Inc. announced on April 14, 2025, that it received a notice of allowance from the US Patent Office for its first patent in the United States for its LockeT product. The patent was filed in December 2022.
This patent specifically covers the design of a surgical closure device for orthoscopic entry wounds. The allowance of this patent strengthens the intellectual property portfolio surrounding the LockeT device.
Securing this US patent is a significant milestone for the LockeT product line. It provides proprietary protection for the device's design, enhancing Catheter Precision's competitive position in the vascular closure market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.